Skip to main content

MAP-5 (50 mg) (Canada)

This page contains information on MAP-5 (50 mg) for veterinary use.
The information provided typically includes the following:
  • MAP-5 (50 mg) Indications
  • Warnings and cautions for MAP-5 (50 mg)
  • Direction and dosage information for MAP-5 (50 mg)

MAP-5 (50 mg)

This treatment applies to the following species:
Company: Vetoquinol

Sterile Sodium Hyaluronate Cryopreservative (5 mg/mL)

Each vial contains: sodium hyaluronate 50.0 mg, sodium chloride USP 85.0 mg, sodium phosphate monobasic dihydrate 0.5 mg, sodium phosphate dibasic dodecahydrate 6.0 mg, water for injection USP q.s. 10 mL. Contains no preservatives. Store at 10-30°C. Veterinary Use Only.

Vétoquinol N.-A. Inc., Lavaltrie, QC, Canada

Vétoquinol USA, Inc., Fort Worth, TX, USA

 

CODE

 

10 mL

439263

100456A

CPN: 1234405.2

VETOQUINOL N.-A. INC.
Commercial Division

2000, CHEMIN GEORGES, LAVALTRIE, QC, J5T 3S5
Telephone:   450-586-2252
Order Desk:   800-363-1700
Fax:   450-586-4649
Website:   www.vetoquinol.ca
Email:   info@vetoquinol.ca
THIS SERVICE AND DATA ARE PROVIDED "AS IS". Animalytix assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the Animalytix service and data. See the Terms of Use for further details.

Copyright © 2023 Animalytix LLC. Updated: 2022-11-29